nodes	percent_of_prediction	percent_of_DWPC	metapath
Dapsone—CYP2E1—Fingolimod—multiple sclerosis	0.127	0.164	CbGbCtD
Dapsone—PTGS2—Triamcinolone—multiple sclerosis	0.0953	0.122	CbGbCtD
Dapsone—PTGS2—Betamethasone—multiple sclerosis	0.0818	0.105	CbGbCtD
Dapsone—CYP2E1—Mitoxantrone—multiple sclerosis	0.0598	0.0769	CbGbCtD
Dapsone—PTGS2—Dexamethasone—multiple sclerosis	0.0476	0.0611	CbGbCtD
Dapsone—CYP3A4—Fingolimod—multiple sclerosis	0.0386	0.0496	CbGbCtD
Dapsone—CYP3A7—Dexamethasone—multiple sclerosis	0.0321	0.0413	CbGbCtD
Dapsone—CYP3A7-CYP3A51P—Dexamethasone—multiple sclerosis	0.0321	0.0413	CbGbCtD
Dapsone—CYP2C19—Prednisone—multiple sclerosis	0.0312	0.04	CbGbCtD
Dapsone—CYP2E1—Dexamethasone—multiple sclerosis	0.031	0.0399	CbGbCtD
Dapsone—CYP3A4—Methylprednisolone—multiple sclerosis	0.0249	0.0319	CbGbCtD
Dapsone—CYP3A5—Dexamethasone—multiple sclerosis	0.0241	0.031	CbGbCtD
Dapsone—CYP2C8—Dexamethasone—multiple sclerosis	0.0232	0.0298	CbGbCtD
Dapsone—CYP2C19—Dexamethasone—multiple sclerosis	0.0194	0.025	CbGbCtD
Dapsone—CYP3A4—Triamcinolone—multiple sclerosis	0.0188	0.0242	CbGbCtD
Dapsone—CYP3A4—Mitoxantrone—multiple sclerosis	0.0181	0.0233	CbGbCtD
Dapsone—CYP2C9—Dexamethasone—multiple sclerosis	0.0162	0.0208	CbGbCtD
Dapsone—CYP3A4—Betamethasone—multiple sclerosis	0.0162	0.0208	CbGbCtD
Dapsone—CYP3A4—Prednisolone—multiple sclerosis	0.0159	0.0205	CbGbCtD
Dapsone—CYP3A4—Prednisone—multiple sclerosis	0.0151	0.0194	CbGbCtD
Dapsone—CYP3A4—Dexamethasone—multiple sclerosis	0.0094	0.0121	CbGbCtD
Dapsone—NAT2—pineal body—multiple sclerosis	0.00898	0.49	CbGeAlD
Dapsone—Nerve injury—Prednisolone—multiple sclerosis	0.00467	0.0553	CcSEcCtD
Dapsone—Nerve injury—Dexamethasone—multiple sclerosis	0.0039	0.0461	CcSEcCtD
Dapsone—Nerve injury—Betamethasone—multiple sclerosis	0.0039	0.0461	CcSEcCtD
Dapsone—Localized exfoliation—Triamcinolone—multiple sclerosis	0.00348	0.0412	CcSEcCtD
Dapsone—Nerve injury—Prednisone—multiple sclerosis	0.0034	0.0402	CcSEcCtD
Dapsone—Influenza—Fingolimod—multiple sclerosis	0.00209	0.0248	CcSEcCtD
Dapsone—Application site reaction—Triamcinolone—multiple sclerosis	0.002	0.0237	CcSEcCtD
Dapsone—Sinusitis—Fingolimod—multiple sclerosis	0.00175	0.0207	CcSEcCtD
Dapsone—PTGS2—leg—multiple sclerosis	0.00163	0.089	CbGeAlD
Dapsone—Proteinuria—Mitoxantrone—multiple sclerosis	0.00142	0.0167	CcSEcCtD
Dapsone—Protein urine present—Mitoxantrone—multiple sclerosis	0.0014	0.0165	CcSEcCtD
Dapsone—Vision blurred—Fingolimod—multiple sclerosis	0.00138	0.0163	CcSEcCtD
Dapsone—Cough—Fingolimod—multiple sclerosis	0.00127	0.0151	CcSEcCtD
Dapsone—Muscular weakness—Cladribine—multiple sclerosis	0.00121	0.0143	CcSEcCtD
Dapsone—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000962	0.159	CbGdCrCtD
Dapsone—Pancreatitis—Azathioprine—multiple sclerosis	0.000947	0.0112	CcSEcCtD
Dapsone—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000947	0.156	CbGdCrCtD
Dapsone—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000947	0.156	CbGdCrCtD
Dapsone—Pharyngitis—Cladribine—multiple sclerosis	0.000943	0.0111	CcSEcCtD
Dapsone—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000925	0.153	CbGdCrCtD
Dapsone—Skin exfoliation—Triamcinolone—multiple sclerosis	0.000896	0.0106	CcSEcCtD
Dapsone—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.000894	0.0106	CcSEcCtD
Dapsone—Erythema—Cladribine—multiple sclerosis	0.000827	0.00978	CcSEcCtD
Dapsone—Skin exfoliation—Betamethasone—multiple sclerosis	0.000813	0.00961	CcSEcCtD
Dapsone—Skin exfoliation—Dexamethasone—multiple sclerosis	0.000813	0.00961	CcSEcCtD
Dapsone—Headache—Fingolimod—multiple sclerosis	0.000746	0.00882	CcSEcCtD
Dapsone—Cough—Cladribine—multiple sclerosis	0.000722	0.00853	CcSEcCtD
Dapsone—Skin exfoliation—Prednisone—multiple sclerosis	0.000708	0.00837	CcSEcCtD
Dapsone—Proteinuria—Methotrexate—multiple sclerosis	0.000705	0.00834	CcSEcCtD
Dapsone—Protein urine present—Methotrexate—multiple sclerosis	0.000696	0.00822	CcSEcCtD
Dapsone—FMO3—nervous system—multiple sclerosis	0.000666	0.0364	CbGeAlD
Dapsone—Psychotic disorder—Methylprednisolone—multiple sclerosis	0.000664	0.00785	CcSEcCtD
Dapsone—Tachycardia—Cladribine—multiple sclerosis	0.000659	0.00779	CcSEcCtD
Dapsone—Muscular weakness—Prednisolone—multiple sclerosis	0.000653	0.00772	CcSEcCtD
Dapsone—Sinusitis—Mitoxantrone—multiple sclerosis	0.000653	0.00772	CcSEcCtD
Dapsone—FMO3—central nervous system—multiple sclerosis	0.000641	0.035	CbGeAlD
Dapsone—Sulfamethazine—ALB—multiple sclerosis	0.000637	0.316	CrCbGaD
Dapsone—Pancreatitis—Prednisolone—multiple sclerosis	0.000628	0.00742	CcSEcCtD
Dapsone—Sulfamerazine—ALB—multiple sclerosis	0.000623	0.309	CrCbGaD
Dapsone—Pharyngitis—Mitoxantrone—multiple sclerosis	0.00062	0.00733	CcSEcCtD
Dapsone—Insomnia—Cladribine—multiple sclerosis	0.000611	0.00722	CcSEcCtD
Dapsone—Psychotic disorder—Betamethasone—multiple sclerosis	0.000604	0.00714	CcSEcCtD
Dapsone—Psychotic disorder—Dexamethasone—multiple sclerosis	0.000604	0.00714	CcSEcCtD
Dapsone—Muscular weakness—Triamcinolone—multiple sclerosis	0.000601	0.0071	CcSEcCtD
Dapsone—Muscular weakness—Methylprednisolone—multiple sclerosis	0.0006	0.00709	CcSEcCtD
Dapsone—Skin exfoliation—Methotrexate—multiple sclerosis	0.000592	0.00699	CcSEcCtD
Dapsone—Influenza—Triamcinolone—multiple sclerosis	0.000589	0.00696	CcSEcCtD
Dapsone—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.00058	0.0958	CbGdCrCtD
Dapsone—Pancreatitis—Triamcinolone—multiple sclerosis	0.000577	0.00682	CcSEcCtD
Dapsone—Pancreatitis—Methylprednisolone—multiple sclerosis	0.000576	0.00681	CcSEcCtD
Dapsone—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000571	0.0943	CbGdCrCtD
Dapsone—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000571	0.0943	CbGdCrCtD
Dapsone—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.00056	0.00661	CcSEcCtD
Dapsone—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000558	0.0921	CbGdCrCtD
Dapsone—Gastrointestinal pain—Cladribine—multiple sclerosis	0.000552	0.00653	CcSEcCtD
Dapsone—Muscular weakness—Betamethasone—multiple sclerosis	0.000545	0.00644	CcSEcCtD
Dapsone—Muscular weakness—Dexamethasone—multiple sclerosis	0.000545	0.00644	CcSEcCtD
Dapsone—Erythema—Mitoxantrone—multiple sclerosis	0.000544	0.00643	CcSEcCtD
Dapsone—Abdominal pain—Cladribine—multiple sclerosis	0.000534	0.00631	CcSEcCtD
Dapsone—Body temperature increased—Cladribine—multiple sclerosis	0.000534	0.00631	CcSEcCtD
Dapsone—Psychotic disorder—Prednisone—multiple sclerosis	0.000526	0.00621	CcSEcCtD
Dapsone—MPO—spinal cord—multiple sclerosis	0.000521	0.0285	CbGeAlD
Dapsone—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.000515	0.00608	CcSEcCtD
Dapsone—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000513	0.00607	CcSEcCtD
Dapsone—Vision blurred—Mitoxantrone—multiple sclerosis	0.000512	0.00606	CcSEcCtD
Dapsone—FMO3—brain—multiple sclerosis	0.000509	0.0278	CbGeAlD
Dapsone—Sulfamethizole—ALB—multiple sclerosis	0.000483	0.24	CrCbGaD
Dapsone—Muscular weakness—Prednisone—multiple sclerosis	0.000475	0.00561	CcSEcCtD
Dapsone—Cough—Mitoxantrone—multiple sclerosis	0.000475	0.00561	CcSEcCtD
Dapsone—Pharyngitis—Triamcinolone—multiple sclerosis	0.000468	0.00553	CcSEcCtD
Dapsone—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000467	0.00552	CcSEcCtD
Dapsone—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000467	0.00552	CcSEcCtD
Dapsone—Pancreatitis—Prednisone—multiple sclerosis	0.000456	0.00539	CcSEcCtD
Dapsone—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.000449	0.00531	CcSEcCtD
Dapsone—Erythema—Prednisolone—multiple sclerosis	0.000446	0.00527	CcSEcCtD
Dapsone—MPO—nervous system—multiple sclerosis	0.000439	0.024	CbGeAlD
Dapsone—Abdominal pain—Azathioprine—multiple sclerosis	0.000434	0.00513	CcSEcCtD
Dapsone—Body temperature increased—Azathioprine—multiple sclerosis	0.000434	0.00513	CcSEcCtD
Dapsone—Tachycardia—Mitoxantrone—multiple sclerosis	0.000433	0.00512	CcSEcCtD
Dapsone—Vomiting—Cladribine—multiple sclerosis	0.000429	0.00507	CcSEcCtD
Dapsone—Headache—Cladribine—multiple sclerosis	0.000423	0.005	CcSEcCtD
Dapsone—MPO—central nervous system—multiple sclerosis	0.000423	0.0231	CbGeAlD
Dapsone—Vision blurred—Prednisolone—multiple sclerosis	0.00042	0.00497	CcSEcCtD
Dapsone—Erythema—Triamcinolone—multiple sclerosis	0.00041	0.00485	CcSEcCtD
Dapsone—Erythema—Methylprednisolone—multiple sclerosis	0.000409	0.00484	CcSEcCtD
Dapsone—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000407	0.00481	CcSEcCtD
Dapsone—Nausea—Cladribine—multiple sclerosis	0.000401	0.00474	CcSEcCtD
Dapsone—Vertigo—Prednisolone—multiple sclerosis	0.000401	0.00474	CcSEcCtD
Dapsone—Pancreatitis—Methotrexate—multiple sclerosis	0.000381	0.00451	CcSEcCtD
Dapsone—Erythema—Betamethasone—multiple sclerosis	0.000372	0.0044	CcSEcCtD
Dapsone—Erythema—Dexamethasone—multiple sclerosis	0.000372	0.0044	CcSEcCtD
Dapsone—Vertigo—Triamcinolone—multiple sclerosis	0.000369	0.00436	CcSEcCtD
Dapsone—Vertigo—Methylprednisolone—multiple sclerosis	0.000368	0.00435	CcSEcCtD
Dapsone—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000363	0.00429	CcSEcCtD
Dapsone—Cough—Triamcinolone—multiple sclerosis	0.000358	0.00423	CcSEcCtD
Dapsone—Tachycardia—Prednisolone—multiple sclerosis	0.000355	0.0042	CcSEcCtD
Dapsone—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000355	0.0042	CcSEcCtD
Dapsone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000351	0.00415	CcSEcCtD
Dapsone—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000351	0.00415	CcSEcCtD
Dapsone—Vomiting—Azathioprine—multiple sclerosis	0.000349	0.00413	CcSEcCtD
Dapsone—Headache—Azathioprine—multiple sclerosis	0.000344	0.00407	CcSEcCtD
Dapsone—MPO—brain—multiple sclerosis	0.000336	0.0183	CbGeAlD
Dapsone—Vertigo—Dexamethasone—multiple sclerosis	0.000334	0.00395	CcSEcCtD
Dapsone—Vertigo—Betamethasone—multiple sclerosis	0.000334	0.00395	CcSEcCtD
Dapsone—Insomnia—Prednisolone—multiple sclerosis	0.000329	0.00389	CcSEcCtD
Dapsone—Tachycardia—Triamcinolone—multiple sclerosis	0.000327	0.00386	CcSEcCtD
Dapsone—Nausea—Azathioprine—multiple sclerosis	0.000326	0.00385	CcSEcCtD
Dapsone—Tachycardia—Methylprednisolone—multiple sclerosis	0.000326	0.00385	CcSEcCtD
Dapsone—Erythema—Prednisone—multiple sclerosis	0.000324	0.00383	CcSEcCtD
Dapsone—Pharyngitis—Methotrexate—multiple sclerosis	0.000309	0.00365	CcSEcCtD
Dapsone—Vision blurred—Prednisone—multiple sclerosis	0.000306	0.00361	CcSEcCtD
Dapsone—Insomnia—Triamcinolone—multiple sclerosis	0.000303	0.00358	CcSEcCtD
Dapsone—Insomnia—Methylprednisolone—multiple sclerosis	0.000302	0.00357	CcSEcCtD
Dapsone—Tachycardia—Dexamethasone—multiple sclerosis	0.000297	0.00351	CcSEcCtD
Dapsone—Tachycardia—Betamethasone—multiple sclerosis	0.000297	0.00351	CcSEcCtD
Dapsone—Vertigo—Prednisone—multiple sclerosis	0.000291	0.00344	CcSEcCtD
Dapsone—Tinnitus—Methotrexate—multiple sclerosis	0.00029	0.00343	CcSEcCtD
Dapsone—CYP2E1—medulla oblongata—multiple sclerosis	0.000288	0.0157	CbGeAlD
Dapsone—Vomiting—Mitoxantrone—multiple sclerosis	0.000282	0.00334	CcSEcCtD
Dapsone—Headache—Mitoxantrone—multiple sclerosis	0.000278	0.00329	CcSEcCtD
Dapsone—Insomnia—Dexamethasone—multiple sclerosis	0.000275	0.00325	CcSEcCtD
Dapsone—Insomnia—Betamethasone—multiple sclerosis	0.000275	0.00325	CcSEcCtD
Dapsone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000273	0.00323	CcSEcCtD
Dapsone—Sulfamethoxazole—ALB—multiple sclerosis	0.000271	0.135	CrCbGaD
Dapsone—Erythema—Methotrexate—multiple sclerosis	0.000271	0.0032	CcSEcCtD
Dapsone—PTGS2—medulla oblongata—multiple sclerosis	0.000265	0.0145	CbGeAlD
Dapsone—Body temperature increased—Triamcinolone—multiple sclerosis	0.000265	0.00313	CcSEcCtD
Dapsone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000264	0.00312	CcSEcCtD
Dapsone—Nausea—Mitoxantrone—multiple sclerosis	0.000264	0.00312	CcSEcCtD
Dapsone—Tachycardia—Prednisone—multiple sclerosis	0.000258	0.00305	CcSEcCtD
Dapsone—CYP2E1—spinal cord—multiple sclerosis	0.000257	0.014	CbGeAlD
Dapsone—Vision blurred—Methotrexate—multiple sclerosis	0.000255	0.00302	CcSEcCtD
Dapsone—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000248	0.00294	CcSEcCtD
Dapsone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000248	0.00294	CcSEcCtD
Dapsone—PTGS1—spinal cord—multiple sclerosis	0.000247	0.0135	CbGeAlD
Dapsone—Vertigo—Methotrexate—multiple sclerosis	0.000243	0.00288	CcSEcCtD
Dapsone—PTGS2—midbrain—multiple sclerosis	0.000242	0.0132	CbGeAlD
Dapsone—Abdominal pain—Dexamethasone—multiple sclerosis	0.00024	0.00284	CcSEcCtD
Dapsone—Abdominal pain—Betamethasone—multiple sclerosis	0.00024	0.00284	CcSEcCtD
Dapsone—Body temperature increased—Dexamethasone—multiple sclerosis	0.00024	0.00284	CcSEcCtD
Dapsone—Body temperature increased—Betamethasone—multiple sclerosis	0.00024	0.00284	CcSEcCtD
Dapsone—Insomnia—Prednisone—multiple sclerosis	0.000239	0.00283	CcSEcCtD
Dapsone—Cough—Methotrexate—multiple sclerosis	0.000236	0.00279	CcSEcCtD
Dapsone—PTGS2—spinal cord—multiple sclerosis	0.000236	0.0129	CbGeAlD
Dapsone—Headache—Prednisolone—multiple sclerosis	0.000228	0.0027	CcSEcCtD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	0.00022	0.00199	CbGpPWpGaD
Dapsone—NAT2—Metabolism—CYP27B1—multiple sclerosis	0.000219	0.00198	CbGpPWpGaD
Dapsone—NAT2—Metabolism—CYP24A1—multiple sclerosis	0.000219	0.00198	CbGpPWpGaD
Dapsone—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000216	0.00256	CcSEcCtD
Dapsone—Nausea—Prednisolone—multiple sclerosis	0.000216	0.00256	CcSEcCtD
Dapsone—CYP2E1—nervous system—multiple sclerosis	0.000216	0.0118	CbGeAlD
Dapsone—PTGS2—S1P1 pathway—MAPK1—multiple sclerosis	0.000214	0.00193	CbGpPWpGaD
Dapsone—Vomiting—Triamcinolone—multiple sclerosis	0.000213	0.00252	CcSEcCtD
Dapsone—Vomiting—Methylprednisolone—multiple sclerosis	0.000212	0.00251	CcSEcCtD
Dapsone—Headache—Triamcinolone—multiple sclerosis	0.00021	0.00248	CcSEcCtD
Dapsone—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.00021	0.00189	CbGpPWpGaD
Dapsone—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.00021	0.00189	CbGpPWpGaD
Dapsone—Headache—Methylprednisolone—multiple sclerosis	0.000209	0.00247	CcSEcCtD
Dapsone—Body temperature increased—Prednisone—multiple sclerosis	0.000209	0.00247	CcSEcCtD
Dapsone—Abdominal pain—Prednisone—multiple sclerosis	0.000209	0.00247	CcSEcCtD
Dapsone—FMO3—Biological oxidations—POMC—multiple sclerosis	0.000209	0.00188	CbGpPWpGaD
Dapsone—PTGS1—nervous system—multiple sclerosis	0.000208	0.0114	CbGeAlD
Dapsone—CYP2E1—central nervous system—multiple sclerosis	0.000208	0.0114	CbGeAlD
Dapsone—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000207	0.00187	CbGpPWpGaD
Dapsone—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000207	0.00187	CbGpPWpGaD
Dapsone—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000207	0.00187	CbGpPWpGaD
Dapsone—MPO—C-MYB transcription factor network—MYC—multiple sclerosis	0.000205	0.00185	CbGpPWpGaD
Dapsone—PTGS2—Overview of nanoparticle effects—TNF—multiple sclerosis	0.000204	0.00184	CbGpPWpGaD
Dapsone—CYP2E1—cerebellum—multiple sclerosis	0.000204	0.0111	CbGeAlD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000201	0.00182	CbGpPWpGaD
Dapsone—PTGS1—central nervous system—multiple sclerosis	0.000201	0.011	CbGeAlD
Dapsone—NAT2—Metabolism—GPC5—multiple sclerosis	0.000201	0.00181	CbGpPWpGaD
Dapsone—Insomnia—Methotrexate—multiple sclerosis	0.0002	0.00236	CcSEcCtD
Dapsone—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—multiple sclerosis	0.000199	0.0018	CbGpPWpGaD
Dapsone—PTGS2—nervous system—multiple sclerosis	0.000199	0.0109	CbGeAlD
Dapsone—Nausea—Triamcinolone—multiple sclerosis	0.000199	0.00235	CcSEcCtD
Dapsone—Nausea—Methylprednisolone—multiple sclerosis	0.000198	0.00235	CcSEcCtD
Dapsone—CYP2C8—brain—multiple sclerosis	0.000196	0.0107	CbGeAlD
Dapsone—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000196	0.00177	CbGpPWpGaD
Dapsone—Vomiting—Dexamethasone—multiple sclerosis	0.000193	0.00228	CcSEcCtD
Dapsone—Vomiting—Betamethasone—multiple sclerosis	0.000193	0.00228	CcSEcCtD
Dapsone—PTGS2—central nervous system—multiple sclerosis	0.000192	0.0105	CbGeAlD
Dapsone—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000191	0.00172	CbGpPWpGaD
Dapsone—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000191	0.00172	CbGpPWpGaD
Dapsone—Headache—Dexamethasone—multiple sclerosis	0.00019	0.00225	CcSEcCtD
Dapsone—Headache—Betamethasone—multiple sclerosis	0.00019	0.00225	CcSEcCtD
Dapsone—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000189	0.0017	CbGpPWpGaD
Dapsone—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000189	0.0017	CbGpPWpGaD
Dapsone—PTGS2—cerebellum—multiple sclerosis	0.000187	0.0102	CbGeAlD
Dapsone—MPO—Folate Metabolism—IL6—multiple sclerosis	0.000187	0.00169	CbGpPWpGaD
Dapsone—MPO—Selenium Micronutrient Network—TNF—multiple sclerosis	0.000184	0.00166	CbGpPWpGaD
Dapsone—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000181	0.00214	CcSEcCtD
Dapsone—Nausea—Dexamethasone—multiple sclerosis	0.00018	0.00213	CcSEcCtD
Dapsone—Nausea—Betamethasone—multiple sclerosis	0.00018	0.00213	CcSEcCtD
Dapsone—Abdominal pain—Methotrexate—multiple sclerosis	0.000175	0.00207	CcSEcCtD
Dapsone—Body temperature increased—Methotrexate—multiple sclerosis	0.000175	0.00207	CcSEcCtD
Dapsone—PTGS2—Spinal Cord Injury—CCR2—multiple sclerosis	0.000174	0.00157	CbGpPWpGaD
Dapsone—CYP3A4—nervous system—multiple sclerosis	0.000174	0.0095	CbGeAlD
Dapsone—Vomiting—Prednisone—multiple sclerosis	0.000168	0.00199	CcSEcCtD
Dapsone—CYP3A4—central nervous system—multiple sclerosis	0.000168	0.00915	CbGeAlD
Dapsone—FMO3—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	0.000167	0.00151	CbGpPWpGaD
Dapsone—NAT2—Metabolism—RRM1—multiple sclerosis	0.000166	0.0015	CbGpPWpGaD
Dapsone—Headache—Prednisone—multiple sclerosis	0.000166	0.00196	CcSEcCtD
Dapsone—CYP2E1—brain—multiple sclerosis	0.000165	0.00903	CbGeAlD
Dapsone—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	0.000164	0.00148	CbGpPWpGaD
Dapsone—PTGS1—brain—multiple sclerosis	0.000159	0.0087	CbGeAlD
Dapsone—CYP3A7—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000159	0.00143	CbGpPWpGaD
Dapsone—FMO3—Metabolism—CYP27B1—multiple sclerosis	0.000159	0.00143	CbGpPWpGaD
Dapsone—FMO3—Metabolism—CYP24A1—multiple sclerosis	0.000159	0.00143	CbGpPWpGaD
Dapsone—Nausea—Prednisone—multiple sclerosis	0.000157	0.00186	CcSEcCtD
Dapsone—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000154	0.00139	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000153	0.00138	CbGpPWpGaD
Dapsone—PTGS2—brain—multiple sclerosis	0.000152	0.00831	CbGeAlD
Dapsone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000151	0.00136	CbGpPWpGaD
Dapsone—MPO—Selenium Micronutrient Network—IL6—multiple sclerosis	0.000148	0.00134	CbGpPWpGaD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	0.000145	0.00131	CbGpPWpGaD
Dapsone—FMO3—Metabolism—GPC5—multiple sclerosis	0.000145	0.00131	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	0.000145	0.00131	CbGpPWpGaD
Dapsone—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000142	0.00128	CbGpPWpGaD
Dapsone—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000142	0.00128	CbGpPWpGaD
Dapsone—Vomiting—Methotrexate—multiple sclerosis	0.000141	0.00166	CcSEcCtD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00014	0.00126	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00014	0.00126	CbGpPWpGaD
Dapsone—Headache—Methotrexate—multiple sclerosis	0.000139	0.00164	CcSEcCtD
Dapsone—CYP2C18—Metabolism—SRM—multiple sclerosis	0.000137	0.00124	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000137	0.00123	CbGpPWpGaD
Dapsone—Nausea—Methotrexate—multiple sclerosis	0.000131	0.00155	CcSEcCtD
Dapsone—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	0.00013	0.00117	CbGpPWpGaD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	0.000129	0.00116	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000128	0.00115	CbGpPWpGaD
Dapsone—CYP2C18—Biological oxidations—POMC—multiple sclerosis	0.000127	0.00115	CbGpPWpGaD
Dapsone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.000126	0.00114	CbGpPWpGaD
Dapsone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.000126	0.00114	CbGpPWpGaD
Dapsone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000124	0.00112	CbGpPWpGaD
Dapsone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000124	0.00112	CbGpPWpGaD
Dapsone—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000123	0.00111	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000121	0.0011	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	0.000121	0.0011	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	0.000121	0.00109	CbGpPWpGaD
Dapsone—FMO3—Metabolism—RRM1—multiple sclerosis	0.00012	0.00108	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	0.000116	0.00105	CbGpPWpGaD
Dapsone—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000115	0.00104	CbGpPWpGaD
Dapsone—CYP3A5—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000115	0.00104	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000111	0.001	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000111	0.001	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	0.00011	0.000995	CbGpPWpGaD
Dapsone—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.00011	0.000988	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	0.000109	0.00098	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000108	0.000973	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000105	0.000952	CbGpPWpGaD
Dapsone—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	0.000105	0.000946	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	0.000104	0.000936	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	0.000101	0.000913	CbGpPWpGaD
Dapsone—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.0001	0.000906	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	0.0001	0.000903	CbGpPWpGaD
Dapsone—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	9.99e-05	0.000901	CbGpPWpGaD
Dapsone—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.95e-05	0.000897	CbGpPWpGaD
Dapsone—FMO3—SIDS Susceptibility Pathways—IL6—multiple sclerosis	9.8e-05	0.000884	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—CYP27B1—multiple sclerosis	9.65e-05	0.000871	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—CYP24A1—multiple sclerosis	9.65e-05	0.000871	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	9.6e-05	0.000866	CbGpPWpGaD
Dapsone—NAT2—Metabolism—BCHE—multiple sclerosis	9.54e-05	0.000861	CbGpPWpGaD
Dapsone—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	9.4e-05	0.000848	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	9.26e-05	0.000835	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	9.24e-05	0.000833	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—SRM—multiple sclerosis	9.11e-05	0.000822	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.02e-05	0.000814	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.02e-05	0.000814	CbGpPWpGaD
Dapsone—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.88e-05	0.000801	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	8.85e-05	0.000799	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—SRM—multiple sclerosis	8.83e-05	0.000796	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—GPC5—multiple sclerosis	8.83e-05	0.000796	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	8.59e-05	0.000775	CbGpPWpGaD
Dapsone—CYP3A7—Biological oxidations—POMC—multiple sclerosis	8.44e-05	0.000761	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	8.24e-05	0.000743	CbGpPWpGaD
Dapsone—PTGS1—Biological oxidations—POMC—multiple sclerosis	8.18e-05	0.000738	CbGpPWpGaD
Dapsone—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.1e-05	0.00073	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	8.05e-05	0.000726	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	8.05e-05	0.000726	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	7.58e-05	0.000683	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	7.53e-05	0.000679	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	7.34e-05	0.000662	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	7.34e-05	0.000662	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—RRM1—multiple sclerosis	7.31e-05	0.00066	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	7.3e-05	0.000659	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—SRM—multiple sclerosis	7.01e-05	0.000632	CbGpPWpGaD
Dapsone—FMO3—Metabolism—BCHE—multiple sclerosis	6.9e-05	0.000622	CbGpPWpGaD
Dapsone—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	6.66e-05	0.000601	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—SRM—multiple sclerosis	6.6e-05	0.000595	CbGpPWpGaD
Dapsone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.59e-05	0.000594	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—SRM—multiple sclerosis	6.58e-05	0.000594	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	6.52e-05	0.000588	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	6.49e-05	0.000586	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—CYP27B1—multiple sclerosis	6.42e-05	0.000579	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—CYP24A1—multiple sclerosis	6.42e-05	0.000579	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—CYP27B1—multiple sclerosis	6.22e-05	0.000561	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—CYP24A1—multiple sclerosis	6.22e-05	0.000561	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	6.14e-05	0.000554	CbGpPWpGaD
Dapsone—CYP2E1—Biological oxidations—POMC—multiple sclerosis	6.11e-05	0.000552	CbGpPWpGaD
Dapsone—CYP3A5—Biological oxidations—POMC—multiple sclerosis	6.1e-05	0.00055	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.08e-05	0.000548	CbGpPWpGaD
Dapsone—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	6.08e-05	0.000548	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	5.98e-05	0.000539	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—GPC5—multiple sclerosis	5.87e-05	0.000529	CbGpPWpGaD
Dapsone—NAT2—Metabolism—APOE—multiple sclerosis	5.74e-05	0.000518	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—SRM—multiple sclerosis	5.7e-05	0.000514	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—GPC5—multiple sclerosis	5.69e-05	0.000513	CbGpPWpGaD
Dapsone—PTGS2—Disease—GPC5—multiple sclerosis	5.39e-05	0.000486	CbGpPWpGaD
Dapsone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.34e-05	0.000482	CbGpPWpGaD
Dapsone—CYP2C8—Biological oxidations—POMC—multiple sclerosis	5.28e-05	0.000477	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—SRM—multiple sclerosis	5.09e-05	0.000459	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	5.08e-05	0.000458	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	5.06e-05	0.000457	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	4.97e-05	0.000448	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—CYP27B1—multiple sclerosis	4.94e-05	0.000445	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—CYP24A1—multiple sclerosis	4.94e-05	0.000445	CbGpPWpGaD
Dapsone—NAT2—Metabolism—POMC—multiple sclerosis	4.93e-05	0.000445	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—RRM1—multiple sclerosis	4.86e-05	0.000439	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.83e-05	0.000435	CbGpPWpGaD
Dapsone—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	4.82e-05	0.000435	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	4.73e-05	0.000426	CbGpPWpGaD
Dapsone—CYP2C19—Biological oxidations—POMC—multiple sclerosis	4.72e-05	0.000426	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—RRM1—multiple sclerosis	4.71e-05	0.000425	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	4.65e-05	0.000419	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	4.65e-05	0.000419	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—SRM—multiple sclerosis	4.64e-05	0.000419	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CYP24A1—multiple sclerosis	4.64e-05	0.000418	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—CYP27B1—multiple sclerosis	4.64e-05	0.000418	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—GPC5—multiple sclerosis	4.52e-05	0.000407	CbGpPWpGaD
Dapsone—NAT2—Metabolism—ALB—multiple sclerosis	4.5e-05	0.000406	CbGpPWpGaD
Dapsone—CYP2C9—Biological oxidations—POMC—multiple sclerosis	4.3e-05	0.000388	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—GPC5—multiple sclerosis	4.25e-05	0.000384	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—GPC5—multiple sclerosis	4.24e-05	0.000383	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—BCHE—multiple sclerosis	4.2e-05	0.000379	CbGpPWpGaD
Dapsone—FMO3—Metabolism—APOE—multiple sclerosis	4.15e-05	0.000374	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	4.02e-05	0.000362	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	4.02e-05	0.000362	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.93e-05	0.000354	CbGpPWpGaD
Dapsone—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	3.82e-05	0.000344	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—RRM1—multiple sclerosis	3.74e-05	0.000338	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—GPC5—multiple sclerosis	3.67e-05	0.000331	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.66e-05	0.00033	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	3.59e-05	0.000324	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	3.59e-05	0.000324	CbGpPWpGaD
Dapsone—FMO3—Metabolism—POMC—multiple sclerosis	3.57e-05	0.000322	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—RRM1—multiple sclerosis	3.52e-05	0.000318	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—RRM1—multiple sclerosis	3.52e-05	0.000317	CbGpPWpGaD
Dapsone—PTGS2—Disease—RPL5—multiple sclerosis	3.51e-05	0.000316	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.5e-05	0.000316	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.45e-05	0.000311	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.44e-05	0.000311	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.38e-05	0.000305	CbGpPWpGaD
Dapsone—PTGS2—Disease—SLC11A1—multiple sclerosis	3.36e-05	0.000303	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—GPC5—multiple sclerosis	3.28e-05	0.000296	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	3.27e-05	0.000295	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	3.27e-05	0.000295	CbGpPWpGaD
Dapsone—FMO3—Metabolism—ALB—multiple sclerosis	3.25e-05	0.000293	CbGpPWpGaD
Dapsone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	3.22e-05	0.00029	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.2e-05	0.000288	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.14e-05	0.000283	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—SRM—multiple sclerosis	3.06e-05	0.000276	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—RRM1—multiple sclerosis	3.04e-05	0.000275	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.99e-05	0.00027	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.9e-05	0.000262	CbGpPWpGaD
Dapsone—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.86e-05	0.000258	CbGpPWpGaD
Dapsone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.84e-05	0.000256	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—BCHE—multiple sclerosis	2.79e-05	0.000252	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.72e-05	0.000245	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—BCHE—multiple sclerosis	2.71e-05	0.000244	CbGpPWpGaD
Dapsone—PTGS2—Disease—CD28—multiple sclerosis	2.68e-05	0.000242	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—APOE—multiple sclerosis	2.53e-05	0.000228	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.49e-05	0.000225	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—RRM1—multiple sclerosis	2.48e-05	0.000224	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.36e-05	0.000213	CbGpPWpGaD
Dapsone—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.27e-05	0.000205	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—POMC—multiple sclerosis	2.17e-05	0.000196	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.16e-05	0.000195	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.16e-05	0.000195	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—BCHE—multiple sclerosis	2.15e-05	0.000194	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.11e-05	0.00019	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.03e-05	0.000183	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—BCHE—multiple sclerosis	2.02e-05	0.000183	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—BCHE—multiple sclerosis	2.02e-05	0.000182	CbGpPWpGaD
Dapsone—CYP2C18—Metabolism—ALB—multiple sclerosis	1.98e-05	0.000179	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.97e-05	0.000178	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.92e-05	0.000173	CbGpPWpGaD
Dapsone—PTGS2—Disease—CD86—multiple sclerosis	1.91e-05	0.000173	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.85e-05	0.000167	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.81e-05	0.000163	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—BCHE—multiple sclerosis	1.75e-05	0.000158	CbGpPWpGaD
Dapsone—PTGS2—Disease—CCR5—multiple sclerosis	1.7e-05	0.000153	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—APOE—multiple sclerosis	1.68e-05	0.000152	CbGpPWpGaD
Dapsone—PTGS2—Disease—HLA-A—multiple sclerosis	1.65e-05	0.000149	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.65e-05	0.000149	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.65e-05	0.000149	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.63e-05	0.000147	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—APOE—multiple sclerosis	1.63e-05	0.000147	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.56e-05	0.000141	CbGpPWpGaD
Dapsone—PTGS2—Disease—APOE—multiple sclerosis	1.54e-05	0.000139	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.51e-05	0.000136	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—POMC—multiple sclerosis	1.44e-05	0.00013	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.42e-05	0.000128	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—POMC—multiple sclerosis	1.4e-05	0.000126	CbGpPWpGaD
Dapsone—PTGS2—Disease—CD80—multiple sclerosis	1.4e-05	0.000126	CbGpPWpGaD
Dapsone—CYP3A7—Metabolism—ALB—multiple sclerosis	1.32e-05	0.000119	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—APOE—multiple sclerosis	1.29e-05	0.000117	CbGpPWpGaD
Dapsone—PTGS1—Metabolism—ALB—multiple sclerosis	1.28e-05	0.000115	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—APOE—multiple sclerosis	1.22e-05	0.00011	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—APOE—multiple sclerosis	1.21e-05	0.00011	CbGpPWpGaD
Dapsone—PTGS2—Disease—TYK2—multiple sclerosis	1.18e-05	0.000106	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—POMC—multiple sclerosis	1.11e-05	0.0001	CbGpPWpGaD
Dapsone—PTGS2—Disease—CD4—multiple sclerosis	1.07e-05	9.61e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—APOE—multiple sclerosis	1.05e-05	9.49e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—POMC—multiple sclerosis	1.05e-05	9.43e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—POMC—multiple sclerosis	1.04e-05	9.41e-05	CbGpPWpGaD
Dapsone—PTGS2—Metabolism—ALB—multiple sclerosis	1.01e-05	9.14e-05	CbGpPWpGaD
Dapsone—CYP2E1—Metabolism—ALB—multiple sclerosis	9.53e-06	8.6e-05	CbGpPWpGaD
Dapsone—CYP3A5—Metabolism—ALB—multiple sclerosis	9.51e-06	8.58e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—APOE—multiple sclerosis	9.39e-06	8.47e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—BCHE—multiple sclerosis	9.39e-06	8.47e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—POMC—multiple sclerosis	9.04e-06	8.15e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—APOE—multiple sclerosis	8.56e-06	7.72e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—STAT3—multiple sclerosis	8.25e-06	7.44e-05	CbGpPWpGaD
Dapsone—CYP2C8—Metabolism—ALB—multiple sclerosis	8.24e-06	7.43e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—POMC—multiple sclerosis	8.07e-06	7.28e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—MYC—multiple sclerosis	7.67e-06	6.92e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—TGFB1—multiple sclerosis	7.65e-06	6.9e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—MAPK1—multiple sclerosis	7.5e-06	6.77e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—POMC—multiple sclerosis	7.36e-06	6.64e-05	CbGpPWpGaD
Dapsone—CYP2C19—Metabolism—ALB—multiple sclerosis	7.35e-06	6.63e-05	CbGpPWpGaD
Dapsone—CYP2C9—Metabolism—ALB—multiple sclerosis	6.71e-06	6.05e-05	CbGpPWpGaD
Dapsone—PTGS2—Disease—IL6—multiple sclerosis	5.76e-06	5.2e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—APOE—multiple sclerosis	5.65e-06	5.09e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—POMC—multiple sclerosis	4.85e-06	4.38e-05	CbGpPWpGaD
Dapsone—CYP3A4—Metabolism—ALB—multiple sclerosis	4.42e-06	3.99e-05	CbGpPWpGaD
